Virtual session: Disease heterogeneity in COVID-19:
an interferon paradox?

Participants

Infectious diseases specialist

Internal medicine specialist

General practitioner

Microbiologist

University researcher

Tropical diseases specialist

Gynecologist

Paediatrician

Immunologist

Industry representative

Other

Private practice

Hospital

Laboratory

Pharmaceutical industry

Other

below 30

31 - 40

41 - 50

51 - 60

61 - 70

over 70